Indeed, despite being upregulated at the messenger RNA level, both in the original Liang at al. gene expression profiles dataset and in the QPCR analyses performed on whole tissue extracts, ZMYM3 protein levels are significantly decreased in severe AD cases, likely influencing total transcriptional activity. This evidence concerns the gene ZMYM3 and Alzheimer disease.